Newsroom

Milliardoppkjøp for gründersuksess -Vi har vært imponerte hele veien , sier bioMérieux-topp Celine Roger-Dalbert. Det franske konsernet legger 1,6 milliarder ...

Kjøpes av fransk magnum-investor SpinChip prises til 1,6 milliarder kroner når selskapet kjøpes av bioMérieux. Les hele artikkelen her.

Milliardoppkjøp for gründersuksess: Prisen åttedoblet på to år – Vi har vært imponert hele veien, sier BioMérieux-topp Celine Roger-Dalbert. Det franske ...

Transaction Valuation: SpinChip valued at NOK 1,624 million (EUR 138 million), making it one of the largest MedTech transactions in ...

Oslo, Norway, 19 November 2024 – SpinChip Diagnostics ASA (“SpinChip”) is pleased to announce the completion of its financing round, ...

With very high diagnostic accuracy, the SpinChip point-of-care (POC) test demonstrated performance comparable to the best-validated central laboratory-based assays. This ...

Oslo, Norway, [22] March 2024 — SpinChip Diagnostics ASA (“SpinChip”), a pioneering diagnostics company developing a next-generation point-of-care platform for ...

Henter inn fransk magnuminvestor: BioMérieux prises til 12 milliarder europå Paris-børsen og har sine røtter i Louis Pasteurs laboratorium. Nå ...

SpinChip Diagnostics has developed a small immunoassays Point of Care (POC) Analyzer that delivers the same diagnostics performance as most ...

Oslo, Norway, 8 January 2024 — SpinChip Diagnostics ASA (“SpinChip”), a pioneering diagnostics company developing a next-generation point-of-care platform for in vitro diagnostics, ...

On December 4th, 2023 SpinChip Diagnostics was converted into a public limited liability company. The name of the company is ...

We are excited to share that SpinChip Diagnostics has successfully obtained ISO 13485:2016 certification for our Quality Management System. In ...

Oslo, (8 June 2023) — SpinChip Diagnostics AS (SpinChip), a pioneering diagnostics company developing a next-generation point-of-care (POC) platform for in ...

Kuttet prisen 60 prosent – fikk inn ny Sveits-investor Christen Sveaas og Patientsky-gründer Jespen Melin Ganc-Petersen måtte godta et solid ...

The financing round finances the design verification and sample comparison study as well as a retrospective study with 3,600 frozen ...

Jakter kvart milliard med priskutt Christen Sveaas, Investinor og MP Pensjon må trolig akseptere redusert verdsetting når SpinChip skal hente ...

We are excited to welcome Glenn Gundersen to the SpinChip team as our new Head of Clinical and Medical Affairs. He will ...

Dear shareholder, It has been an eventful year so far, however the next couple of years are expected to be ...

The SpinChip cartridge holds integrated both liquid and dried reagents. The microfluidic designs are specifically designed to process the sample ...

Satser 30 millioner kroner på ekspress-blodprøver SpinChip slet på sin forrige emisjonsrunde, men denne gangen ble det klaff. Selskapet henter ...